In this study, in HCT-116 and HT-29 cells, we found that GAS5 significantly inhibit the release of IL-10 and VEGF-A, which indicates that GAS5 is involved in the tumour-associated inflammatory response. This evidence concerns the gene GAS5 and neoplasm.